Company intelligence / Profile preview

Thomas Weisel Healthcare Venture Partners

San Francisco, California, USA

Ownership: Private
Development stage: Other

Overview

Thomas Weisel Healthcare Venture Partners (TWHVP) was a specialized venture capital fund focused on the healthcare and life sciences sectors. Established in 2003 as a division of the investment bank Thomas Weisel Partners, the fund managed approximately $122 million and invested in early-stage biotechnology, biopharmaceutical, and medical technology companies. The firm's healthcare investment team later transitioned to form Kearny Venture Partners, and the fund's parent company was acquired by Stifel Financial in 2010. TWHVP played a key role in financing emerging healthcare innovations during the early 2000s.

Industry: Investors

Beyond the preview

Go deeper on Thomas Weisel Healthcare Venture Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thomas Weisel Healthcare Venture Partners.

Explore the full profile